IL1B and neoplasm: The granulocyte–macrophage colony-stimulating factor is one of the downstream effects released via IL-1β, which enhances the synthesis of M2-type macrophages and myeloid-derived suppressor cells (MDSCs) for promoting tumor invasion, immune escape, and tumor growth (Garon et al. 2020).